Ona Therapeutics
PrivateLast Round
Series B
Jun 4, 2026
Total Funding Raised
$86.6M
Company Overview
Ona Therapeutics is a biopharmaceutical company developing first-in-class antibody-drug conjugates (ADCs) to address treatment-resistant cancers.
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ona Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Ona Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 4, 2026 | ||||
| Series A | Jun 16, 2020 | ||||
| Seed | May 21, 2019 |
Key People
Founding team and executive leadership
Ona Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | Series B, Series A |
| Alta Life Sciences | Series A, Series B |
| Fund+ | Series A, Series B |
| Korys | Series B |
| Ysios Capital | Series A, Series B |
| Bpifrance | Series B |
| Innvierte Economía Sostenible | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 4, 2026
$87M round led by Mérieux Equity Partners and Columbus Venture Partners.
- Mar 14, 2025
Monthly visitors increased 123% MoM.
Ona Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ona Therapeutics's valuation, stock price, and market status.
